Navigation Links
Sangamo BioSciences Reports Third Quarter 2008 Financial Results

September 30, September 30,

2008 2007 2008 2007

Consolidated Statement of Operations



Collaboration agreements $3,196 $1,915 $7,658 $4,526

Research grants 549 410 1,694 1,805

Total revenues 3,745 2,325 9,352 6,331

Operating expenses:

Research and development 7,563 5,916 24,492 17,655

General and administrative 2,564 1,728 8,036 5,840

Total operating expenses 10,127 7,644 32,528 23,495

Loss from operations (6,382) (5,319) (23,176) (17,164)

Interest income, net 42 1,051 1,448 2,356

Net loss $(6,340) $(4,268) $(21,728) $(14,808)

Basic and diluted net loss per

common share $(0.15) $(0.11) $(0.53) $(0.41)

Shares used in computing basic and

diluted net loss per common share 40,928 38,925 40,759 36,387


September 30, 2008 December 31, 2007

Cash, cash equivalents, and investments $59,458 $81,412

Total assets 70,749 83,900

Total stockholders' equity 56,021 72,122

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
3. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
4. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
5. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
6. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
7. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
8. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
9. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
10. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
11. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
Post Your Comments:
(Date:12/19/2014)... Lawrence, MA (PRWEB) December 19, 2014 ... flow MRLAFMQ test for the Detection of Aflatoxin M1 ... test to receive independent third party validation. The peer ... Science Unit of the Institute for Agricultural and Fisheries ... Francis Group. , Aflatoxin B1, the most toxic ...
(Date:12/19/2014)... , Dec. 19, 2014 Naurex Inc., a ... drugs for diseases of the central nervous system, today ... chief executive officer, will present at the 33 rd ... will take place at 3:00 p.m. PST on Tuesday, ... San Francisco, Calif. ...
(Date:12/19/2014)... REDWOOD CITY, Calif. , Dec. 19, 2014 ... , USA) announced today that they have been ... Technologies 1,2 is a privately held company that ... processing of next generation sequencing (NGS) data for the ... into the Roche Sequencing Unit, and will continue to ...
(Date:12/19/2014)... --Research and Markets ( ) ... Innovations in Smart Fabrics (Technical Insights)" report ... The Research Service titled ... assessment on technological advancements and market for Smart ... 1. The Smart Fabrics market is expected to ...
Breaking Biology Technology:Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3Technology Innovations in Smart Fabrics (Technical Insights) 2
... Inc. (Nasdaq: INSM ), a biopharmaceutical company, today ... Index following Russell Investments, reconstitution of its comprehensive set of ... Insmed was also added to the Russell Microcap(R) Index. , ... 4,000 largest U.S. stocks as of the end of May, ...
... , BOTHELL, WA, and VANCOUVER, June 30 /PRNewswire-FirstCall/ - ... biopharmaceutical company committed to the development and commercialization of ... of cancer, announced today that the Company was added ... and the Russell Microcap(R) Index at the close of ...
... ... the release of a comprehensive global report on Small Molecule Kinase Inhibitors ... reach $16.2 billion by the year 2015. This is primarily driven by ... and modifying protein kinase triggered tumor cell metabolism, proliferation, and DNA damage. ...
Cached Biology Technology:Insmed Announces Addition to the Russell 3000(R) Index 2OncoGenex Pharmaceuticals Added to Russell Indexes 2OncoGenex Pharmaceuticals Added to Russell Indexes 3Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc. 2Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc. 3
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/17/2014)... -- Automation is fundamentally transforming the travel experience and ... borders. Over the past decade, ePassports, biometric readers, ... to self process through border control via eGates ... increasing number of airports, seaports, and land borders ... Maxine Most , Principal at Acuity Market ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( ) has announced the ... APAC Region 2015-2019"  report to their offering. ... market is advances in technology. With continuous advances ... solutions to the latest standard that meets the ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... WINSTON-SALEM, N.C., July 18, 2013 -- Scientists at Wake Forest ... the cumulative effect of impacts to the head incurred by ... (RWE), can capture players, exposure to the risk of concussion ... frequency and magnitude of all impacts, said senior author of ...
... now open for the Mushrooms and Health Summit held at ... 2013. The meeting is of interest to scientists, writers and ... examination of the global research that links mushrooms to today,s ... event , Learn from the world,s top scientists, researchers ...
... have identified biochemical changes in people taking antidepressants ... occur in a neurotransmitter pathway that is connected to ... that controls the sleep cycle, suggesting an added link ... published on July 17, 2013, in the journal ...
Cached Biology News:Scientists develop new way to measure cumulative effect of head hits in football 2Scientists develop new way to measure cumulative effect of head hits in football 3Biochemical mapping helps explain who will respond to antidepressants 2Biochemical mapping helps explain who will respond to antidepressants 3
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5...
RayBio L Series 507: RayBio Label-based Antibody Array I (1 glass slide with 2 subarrays) Class: Antibody Array Products Product Group: Antibody Array...
Rat CXCL7/Thymus Chemokine-1 DuoSet Economy Pack, 45 Plate...
Biology Products: